期刊文献+

卵巢浆液性和黏液性交界性肿瘤36例临床病理特点 被引量:2

Clinicopathological Characteristics of 36 Cases with Ovarian Mucinous/Serous Borderline Tumors
原文传递
导出
摘要 目的探讨卵巢浆液性和粘液性交界性肿瘤的临床病理特点。方法对钦州市第一人民医院收治的36例卵巢浆液性和粘液性交界肿瘤临床资料及病理特点进行回顾性分析。结果浆液性和黏液性交界性肿瘤缺乏特异的临床表现。Ⅰ期浆液性交界瘤17例(81%),黏液性交界瘤12例(80%)。Ⅱ期浆液性交界瘤3例(14.3%),黏液性交界瘤2例(13.3%)。Ⅲ期浆液性交界瘤1例(4.8%),黏液性交界瘤1例(6.7%)。有4例浆液性交界瘤淋巴结受累。有3例浆液性交界瘤为非浸润性种植,1例浆液性交界瘤为浸润性种植,1例黏液性交界瘤为浸润性种植。治疗以手术为主。术后随访110年,有1例Ⅲ期黏液性交界瘤患者术后5年死亡,其余健在。结论卵巢浆液性交界瘤预后较好,肿瘤在卵巢表面生长常有腹膜种植。 Objective To explore the clinicopathological characteristics of ovarian mucinous/serous borderline tumors.Methods Retrospective study was undertaken to 36 cases of patients suffering ovarian mucinous/serous borderline tumors treated in our hospital.Results The ovarian mucinous/serous borderline tumors lacked for specific and differential clinical manifestation.At stage Ⅰ,borderline serous tumors occurred in 17 cases(81%),and borderline mucinous tumors in 12 cases(80%).At stage Ⅱ,borderline serous tumors occurred in 3 cases(14.3%),and borderline mucinous tumors in 2 cases(13.30%).At stage Ⅲ,borderline serous tumors occurred in 1 case(4.8%),and borderline mucinous tumors in 1 case(6.70%).4 patients with borderline serous tumors suffered from lymph node.Borderline serous tumors in 3 patients were non-invasive implantation;borderline serous tumors in 1 patient were invasive implantation;borderline mucinous tumors in 1 patient were invasive implantation.Treatment was chiefly based on surgery.In the follow-up of 1 to 10 years,1 case at Stage Ⅲ with borderline mucinous tumors died in 5 years after surgery,while other patients are still living.Conclusion Borderline ovarian serous tumors had better prognosis,tumors growing on ovarian surface usually had peritoneum implantation.
作者 杨丹球
出处 《中华全科医学》 2011年第5期730-732,共3页 Chinese Journal of General Practice
关键词 卵巢肿瘤 交界性瘤 临床病理 预后 Ovarian tumors Borderline tumors Clinicopathology Prognosis
  • 相关文献

参考文献12

  • 1Allison KH, Swisher EM, Kerkering KM,et al. Defining an app rop ri- ate threshold for the diagnosis of serous borderline tumor of the ovary : when is a full staging procedure unnecessary? [ J ]. Int J Gynecol Pathol,2008,27 ( 1 ) :10-17.
  • 2De Iaco P, Ferrero A, Rosati F, et al. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery [ J ]. Eur J Surg Oncol,2009,35 (6) :643-648.
  • 3刘爱军,陈乐真.WHO肿瘤国际组织学新分类(下)[M].北京:诊断病理学杂志出版社,2001:68-82.
  • 4Crispens MA. Borderline ovarian tumours : a review of the recent litera- ture [ J ]. Currop in Obstet Gynecol,9003,15 ( 1 ) :39-43.
  • 5Ren J, Peng Z, Yang K. A clinicopathologic rnuhivariate analysis af- fecting recurrence of borderline ovarian tumors [ J ]. Gynecol Oncol, 2008,110(2) :162-167.
  • 6Trimble CL, Kosary C ,Trimble EL. Long-term survival and patterns of care in women withovarian tumors of low maligant potential[ J]. Gyne- col Oncol,2002,86( 1 ) :34-37.
  • 7糜若然,瞿全新.卵巢交界性瘤[J].中国实用妇科与产科杂志,2003,19(8):460-462. 被引量:4
  • 8Park JY, Kim DY, Kim JH, et al. Surgical management of borderline o- varian tumors:The role of fertility sparing surgery[ J ]. Gynecol Oncol, 2009,113(1) :75- 82.
  • 9Kokawa K, Mikami Y, Sakata H, et al. Clinical outcome and progn-os-tic factors in borderline tumors of the ovary. Results from 17 years'ex- perience in the Kinki District of Japan(1990-2006) [ J ]. Eur J Gynae- col Oncol,2009,30(2) :155-161.
  • 10Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary(low-grade) serous carcinoma of the ovary [ J ]. Am J Surg Pathol,2003,27 ( 6 ) :725-736.

二级参考文献26

  • 1郭丽娜,连利娟,刘彤华.卵巢浆液性交界性肿瘤腹膜种植的临床与病理学研究[J].中华妇产科杂志,1996,31(5):287-290. 被引量:5
  • 2糜若然主编.妇科肿瘤基因诊断与治疗[M].北京:人民卫生出版社,2002..
  • 3Zanotti KM, Hart WR, Kennedy AW, et al. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors. Int J Gynecol Pathol,1999,18(3) :247.
  • 4Hu J, Khanna MM, Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet, 2002,139(1) :18.
  • 5Kiziridou AD,Toliou T, Stefanou D, et al. u-PA expression in benign, borderline and malignant ovarian tumors. Anticancer Res,2002,22(2A) :958.
  • 6Deavers MT, Gershenson DM,Torrolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential :a study of 99 advanced stage cases. Am J Surg Pathol,2002,26(9) :1129.
  • 7Gotlieb WH, Soriano D, Achiron R, et al. CA125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol,2000,183 (3) :541.
  • 8Engelen MJ,de Bruijn HW,Hollema H,et al. Serum CA125 carcinomoryonic antigen,and CA19-9 as tumor markers in borderline ovarian. Gynecol 0ncol,2002,28( 1 ) :16.
  • 9Camatte S, Morice P, Atallah D, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor:an analysis of a series of 42 lymphadenectomies. J Am Coll Surg,2002,195(3) :332.
  • 10Bell KA, Smith Sehdev AE, Kurman RJ.Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas[J]. Am J Surg Pathol, 2001,25(4):419-432.

共引文献12

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部